274 related articles for article (PubMed ID: 21498541)
21. ¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Kaira K; Yamamoto N; Endo M; Kenmotsu H; Naito T; Ono A; Murakami H; Ohde Y; Nakajima T; Takahashi T
Oncol Rep; 2014 Jan; 31(1):209-15. PubMed ID: 24173608
[TBL] [Abstract][Full Text] [Related]
22. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Buck AK; Halter G; Schirrmeister H; Kotzerke J; Wurziger I; Glatting G; Mattfeldt T; Neumaier B; Reske SN; Hetzel M
J Nucl Med; 2003 Sep; 44(9):1426-31. PubMed ID: 12960187
[TBL] [Abstract][Full Text] [Related]
23. Oxidized low-density lipoprotein stimulates macrophage 18F-FDG uptake via hypoxia-inducible factor-1α activation through Nox2-dependent reactive oxygen species generation.
Lee SJ; Thien Quach CH; Jung KH; Paik JY; Lee JH; Park JW; Lee KH
J Nucl Med; 2014 Oct; 55(10):1699-705. PubMed ID: 25214643
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.
Lohith TG; Kudo T; Demura Y; Umeda Y; Kiyono Y; Fujibayashi Y; Okazawa H
J Nucl Med; 2009 Dec; 50(12):1948-53. PubMed ID: 19910425
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging.
Chung JH; Cho KJ; Lee SS; Baek HJ; Park JH; Cheon GJ; Choi CW; Lim SM
J Nucl Med; 2004 Jun; 45(6):999-1003. PubMed ID: 15181136
[TBL] [Abstract][Full Text] [Related]
26. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ
J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884
[TBL] [Abstract][Full Text] [Related]
27. ¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?
Kaira K; Endo M; Shukuya T; Kenmotsu H; Naito T; Ono A; Tsuya A; Nakamua Y; Takahashi T; Murakami H; Kondo H; Nakajima T; Yamamoto N
Neoplasma; 2012; 59(3):257-63. PubMed ID: 22329847
[TBL] [Abstract][Full Text] [Related]
28. Correlation of HIF-1α/HIF-2α expression with FDG uptake in lung adenocarcinoma.
Higashi K; Yamagishi T; Ueda Y; Ishigaki Y; Shimasaki M; Nakamura Y; Oguchi M; Takegami T; Sagawa M; Tonami H
Ann Nucl Med; 2016 Dec; 30(10):708-715. PubMed ID: 27663442
[TBL] [Abstract][Full Text] [Related]
29. Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.
Norikane T; Yamamoto Y; Maeda Y; Kudomi N; Matsunaga T; Haba R; Iwasaki A; Hoshikawa H; Nishiyama Y
Nucl Med Commun; 2014 Jan; 35(1):30-5. PubMed ID: 24121312
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C
Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791
[TBL] [Abstract][Full Text] [Related]
32. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
Bos R; van Der Hoeven JJ; van Der Wall E; van Der Groep P; van Diest PJ; Comans EF; Joshi U; Semenza GL; Hoekstra OS; Lammertsma AA; Molthoff CF
J Clin Oncol; 2002 Jan; 20(2):379-87. PubMed ID: 11786564
[TBL] [Abstract][Full Text] [Related]
33. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM
J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Duan Y; Yu LJ; Lu PO; Wang WZ
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
[TBL] [Abstract][Full Text] [Related]
35. Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
Jeong YJ; Jung JW; Cho YY; Park SH; Oh HK; Kang S
Nucl Med Rev Cent East Eur; 2017; 20(1):32-38. PubMed ID: 28198519
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung adenocarcinoma].
Wang T; Sun YE; Yao SL; Tian JH; Liu XB; Wang K
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(16):968-71. PubMed ID: 15363231
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
[TBL] [Abstract][Full Text] [Related]
38. The Effect of GLUT1 and HIF-1α Expressions on Glucose Uptake and Patient Survival in Non-Small-Cell Lung Carcinoma.
Kokeza J; Strikic A; Ogorevc M; Kelam N; Vukoja M; Dilber I; Zekic Tomas S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445752
[TBL] [Abstract][Full Text] [Related]
39. The role of ¹⁸F-FDG uptake features in the differential diagnosis of solitary pulmonary lesions with PET/CT.
Zhao M; Chang B; Wei Z; Yu H; Tian R; Yuan L; Jin H
World J Surg Oncol; 2015 Sep; 13():271. PubMed ID: 26369407
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer.
Schreurs LM; Smit JK; Pavlov K; Pultrum BB; Pruim J; Groen H; Hollema H; Plukker JT
Ann Surg Oncol; 2014 Nov; 21(12):3751-7. PubMed ID: 24939624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]